q&more
My watch list
my.chemie.de  
Login  

Author

Prof. Dr. Peter Ertl

Technische Universität Wien, Institut für Angewandte Synthesechemie

Univ. Prof. Dipl.-Ing. Dr. Peter Ertl

Peter Ertl, born in 1970, studied food and biotechnology at the University of Natural Resources and Applied Life Sciences, Vienna. He obtained a PhD in chemistry from the University of Waterloo, Canada, and subsequently spent several years as a postdoc at the University of California at Berkeley. In 2003, Dr. Ertl founded RapidLabs Inc., a biotech start-up active in the field of bacterial resistance to antibiotics, at which he was Director of Product Development until 2005. In 2006, after eight years in North America, he returned to Austria to establish a microfluidics research group in the BioSensor Technology unit of the Austrian Institute of Technology as a senior scientist. After several scientific functions as a visiting scientist at UC Berkeley (Fulbright Scholarship 2012), Nanyang Technological University in Singapore and University of California’s San Francisco Medical Center, and qualifying as a professor in nanobiotechnology, Dr. Ertl was appointed Professor for Lab-on-a-Chip Systems in Bioscience Technologies at the Faculty of Technical Chemistry of Vienna University of Technology in 2016. His research focuses on the development of chip-based human disease models, so-called organ-on-a-chip systems, to investigate disease and healing processes in the context of personalized medicine.

Leitmotif

Organ-on-a-Chip ROCKS

Activities

In his more than 20-year scientific career, Dr. Ertl has specialized in the development of biosensors and lab-on-a-chip systems for biomedical applications. He is also co-founder and CTO of SAICO Biosystems KG. Dr. Ertl is a member of various scientific and industrial advisory boards, editor of the open access journal Organs-on-a-Chip, speaker of the Austrian Microfluidics Initiative (AMI) and visiting scientist at the Imperial College London.

Awards

For developing a personalized midbrain-on-a-chip model (Parkinson-on-a-Chip) to understand neurodegenerative processes, Professor Peter Ertl and his team were awarded the 2020 Houska Prize (3d Audience Prize) in the category “Higher Education Research”.

Focus

Professor Peter Ertl's “Cell Chip Group” at Vienna University of Technology focuses on researching and establishing complex in vitro organ and disease models, which are studied in credit card sized microchips. This novel technology makes it possible to precisely mimic and control human physiological processes for medical research. The group also works on developing highly integrated lab-on-a-chip systems, focusing on industrial design criteria, the standardization of organ-on-a-chip technology as well as prototyping and large-scale manufacturing.

Methods

  • Rapid prototyping of microfluidic biochips including design, simulation and system integration
  • 2D and 3D cell biology including single cells, multicellular systems, spheroids and organoids
  • Optical and electrical biosensors
  • Self-powered sensing applications

Facts, background information, dossiers

  • personalized medicine
  • biosensors
  • lab-on-a-chip systems
  • in vitro organ models
  • disease models
  • 2D cell culture
  • 3D cell cultures
  • cell spheroids
  • organoids

Other articles by this author

All articles

Organs-on-a-Chip

The aim of personalized medicine (or precision medicine) is to take patients’ personal features into consideration as much as possible for their medical treatment, thereby going beyond the (…)

More about TU Wien

  • News

    New Biochip Technology for Pharma Research

    In pharmaceutical research, small tissue spheres are used as mini-organ models for reproducible tests. TU Wien has found a way to develop a reliable standard for these tissue samples. Before drugs are tested in clinical trials, they must be tested either by animal experiments or, more recen ... more

    Nanoparticles: The Complex Rhythm of Chemistry

    Most of commercial chemicals are produced using catalysts. Usually, these catalysts consist of tiny metal nanoparticles that are placed on an oxidic support. Similar to a cut diamond, whose surface consists of different facets oriented in different directions, a catalytic nanoparticle also ... more

    Tracking down the tiniest of forces: how T cells detect invaders

    T-cells play a central role in our immune system: by means of their so-called T-cell receptors (TCR) they make out dangerous invaders or cancer cells in the body and then trigger an immune reaction. On a molecular level, this recognition process is still not sufficiently understood. Intrigu ... more

  • q&more articles

    Organs-on-a-Chip

    The aim of personalized medicine (or precision medicine) is to take patients’ personal features into consideration as much as possible for their medical treatment, thereby going beyond the functional diagnosis of the disease. A promising concept that is gaining ever more attention and showi ... more

  • Authors

    Sarah Spitz

    Sarah Spitz, born in 1993, studied biotechnology at the University of Natural Resources and Applied Life Sciences (BOKU) in Vienna, graduating with an engineering diploma degree. While studying, she was employed for two years as a research assistant at the Department of Biotechnology (DBT) ... more

    Dr. Kurt Brunner

    Kurt Brunner, born in 1973 graduated in Technical Chemistry from TU Vienna before obtaining his doctorate from the University’s Institute of Chemical Engineering in 2003. While preparing his thesis, he worked on the molecular biology of fungi. Following research work conducted at the Univer ... more

    Prof. Dr. Marko D. Mihovilovic

    Marko D. Mihovilovic graduated in technical chemistry at the Vienna University of Technology in 1993, also receiving his doctorate from the same university in 1996, in the field of organic synthetic chemistry. Post-doc placements as an Erwin Schrödinger scholarship holder then followed at t ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:

 

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE